Treatment of Skin-Limited Leukocytoclastic Vasculitis Without an Identifiable Drug or Infection Trigger
This protocol addresses leukocytoclastic vasculitis confined to the skin in patients where no causative drug reaction or active infection has been identified as the precipitating trigger.
Clinical Scenario
When leukocytoclastic vasculitis is limited to the skin and no identifiable drug reaction or infection trigger is found, management focuses on symptomatic relief. The majority of acute episodes of cutaneous small vessel vasculitis in this setting are self-limited and do not recur, even without treatment.
Treatment Approach
The approach centres on conservative supportive measures — including physical strategies to minimise lower-limb venous pooling — with a short pharmacological course reserved for cases that require it.
The complete regimen, sequencing, and prescribing details are available in the full structured protocol.
Clinical Goal
Resolution of cutaneous vasculitis lesions within 3–4 weeks
References
DOI: 10.1093/rheumatology/keac115
If LCV is limited to the skin, the management strategy should mostly focus on symptomatic relief, since the majority of acute episodes of cutaneous SVV are self-limited and do not recur, even without treatment.
Rest (avoiding prolonged standing or walking) and elevation and use of compression stockings should be advised in all cases.
Most episodes of single-organ cutaneous LCV are self-limited, resolve over 3–4 weeks, with or without residual hyperpigmentation, and do not recur.
View source ↗